Peripac S Paclitaxel Eluting Peripheral Stent System

A drug-eluting stent system designed for peripheral vascular applications. It provides structural support while releasing therapeutic agents to reduce restenosis in peripheral arteries.

Drug-eluting stent for peripheral vascular interventions. Designed to expand narrowed peripheral vessels and maintain vessel patency.

Peripheral drug-eluting stent for arterial disease treatment, delivering sirolimus to prevent restenosis in peripheral vasculature.

Peripheral drug-eluting stent system for treatment of peripheral arterial disease with anti-restenosis drug coating.

Interventional device for treating peripheral artery disease in lower extremities and other peripheral vessels. Restores blood flow in stenosed or occluded peripheral arteries.

Bioresorbable drug-eluting stent system designed for peripheral vascular intervention in patients with stenotic or occluded peripheral arteries. The stent gradually resorbs while delivering therapeutic agents to prevent restenosis, restoring blood flow in lower extremity and other peripheral vascular applications.

A coronary stent system designed to deliver therapeutic agents directly to arterial lesions, reducing restenosis rates in percutaneous coronary intervention procedures. Manufactured in Vietnam with proven clinical efficacy and biocompatibility.

Advanced stent platform with pharmaceutical coating for coronary applications. Reduces restenosis risk while maintaining vessel patency in patients with coronary artery disease.

Interventional device designed for coronary artery disease treatment through percutaneous coronary intervention procedures. Provides structural support to maintain vessel patency in diseased coronary arteries.

Drug-eluting coronary stent for percutaneous transluminal coronary angioplasty reducing restenosis in atherosclerotic lesions.

Bioabsorbable sirolimus-eluting stent system designed for percutaneous coronary intervention (PCI) in coronary artery disease. The stent delivers sirolimus to inhibit neointimal hyperplasia while the polymer scaffold gradually resorbs, restoring vasomotor function. Indicated for patients with de novo coronary lesions requiring revascularization.

A peripheral stent designed for peripheral intervention procedures. The product is manufactured using precision laser engraving, chemical acid pickling, heat treatment processes, and electrochemical polishing. It is cut from materials including 316L stainless steel, cobalt-chromium alloy, nickel-titanium alloy, and magnesium-zinc alloy, with surface treatments such as electrochemical polishing, acid pickling, passivation, and sandblasting.